
Sulfamet M 3mg/500mg Tablet SR
Marketer
Tasyca Pharma Pvt Ltd
Salt Composition
Glimepiride (3mg) + Metformin (500mg)
Overview Sulfamet M 3mg/500mg Tablet SR
Diabexe Duo 3mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Diabexe Duo should be administered with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as premature discontinuation, without medical consultation, risks elevated glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan, incorporating a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications are essential for successful diabetes control. The most frequent adverse reaction to Diabexe Duo is hypoglycemia (low blood sugar). Familiarize yourself with hypoglycemia symptoms, including sweating, lightheadedness, headache, and tremors, and know how to manage them promptly. Maintain regular mealtimes and carry a readily available glucose source, such as sugary snacks or juice. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Other possible side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may also occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Patients with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.
Primary Ingredients of Sulfamet M 3mg/500mg Tablet SR
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Sulfamet M 3mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Sulfamet M 3mg/500mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Sulfamet M 3mg/500mg Extended-Release Tablets should be administered with a meal.
Common Side effects of Sulfamet M 3mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Sulfamet M 3mg/500mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take the Sulfamet M 3mg/500mg Extended-Release tablet with food.
How Sulfamet M 3mg/500mg Tablet SR works:
Sulfamet M 3mg/500mg Extended-Release tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Sulfamet M 3mg/500mg SR tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The extended-release Sulfamet M 3mg/500mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Prolonged-release Sulfamet M 3mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when administering Sulfamet M 3mg/500mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Sulfamet M 3mg/500mg SR tablets are contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Sulfamet M 3mg/500mg SR tablets cautiously, potentially requiring dosage modification. Individuals with mild to moderate hepatic dysfunction may begin with a reduced dose; however, the medication is contraindicated in those with severe liver disease. Physician consultation is advised.
What if you forget to take Sulfamet M 3mg/500mg Tablet SR :
Should you forget to take your Sulfamet M 3mg/500mg Tablet SR, administer the dose as soon as you remember. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Sulfamet M 3mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
